AbbVie Inc.
ABBV- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551152
In the last 90 days, AbbVie Inc. insiders filed 0 open-market purchases and 1 sale; 4,238 institutions reported holding it in 13F filings for Q2 2026, worth $335.4B in total; superinvestors Gardner Russo & Quinn and Harris Associates (Oakmark) hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by AbbVie Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $8.18M in total
- Insiders trading
- 1
- Net value
- −$8.18M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for AbbVie Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | 74,430 | Aug 18, 2026 | 3 |
| Rapp Edward J | Director | 45,964 | Jul 2, 2026 | 5 |
| Quaggin Susan E | Director | 3,643 | Jul 2, 2026 | 5 |
| Austin Roxanne S | Director | 39,576 | May 12, 2026 | 1 |
| Falk Thomas J | Director | 2,321 | May 12, 2026 | 1 |
| Waddell Frederick H | Director | 30,076 | May 12, 2026 | 1 |
| Freyman Thomas C | Director | 127,869 | May 12, 2026 | 1 |
| Roberts Rebecca B | Director | 14,846 | May 12, 2026 | 1 |
| Hart Brett J | Director | 20,590 | May 12, 2026 | 1 |
| Burnside William H.L. | Director | 28,076 | May 12, 2026 | 1 |
| Meyer Melody B | Director | 17,616 | May 12, 2026 | 1 |
| Davis Jennifer L. | Director | 3,643 | May 12, 2026 | 1 |
| Alpern Robert J | Director | 35,646 | Apr 2, 2026 | 3 |
| Purdue David Ryan | SVP, Controller | 8,468 | Mar 11, 2026 | 3 |
| Crum Demetris D | EVP, CHIEF HR OFFICER | 7,914 | Mar 6, 2026 | 2 |
| Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | 197,794 | Mar 3, 2026 | 2 |
| Michael Robert A. | CHAIRMAN OF THE BOARD AND CEO | 178,737 | Mar 3, 2026 | 2 |
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | 83,171 | Mar 3, 2026 | 2 |
| Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | 38,777 | Mar 3, 2026 | 2 |
| Siatis Perry C | EVP, GC AND SECRETARY | 4,619 | Mar 3, 2026 | 3 |
| Thakkar Roopal | EVP, R&D and CSO | 52,376 | Mar 3, 2026 | 2 |
| Tilton Glenn F | Director | 51,564 | May 13, 2025 | 0 |
| Gonzalez Richard A | Director | 386,479 | Apr 2, 2025 | 0 |
| Richmond Timothy J. | EVP, CHIEF HR OFFICER | 6,130 | Mar 4, 2025 | 0 |
| Buckbee Kevin K | SVP, CONTROLLER | 7,797 | Mar 4, 2025 | 0 |
| Hudson Thomas J | SVP, CSO, GLOBAL RESEARCH | 107,267 | Mar 1, 2024 | 0 |
| Strom Carrie C | SVP & PRES GLOBAL ALLERG AESTH | 28,024 | May 12, 2023 | 0 |
| Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | 35,330 | Apr 27, 2023 | 0 |
| Durkin Brian L | VP, CONTROLLER | 33,149 | Mar 2, 2023 | 0 |
| Severino Michael | Vice Chairman | 152,103 | May 25, 2022 | 0 |
| Gosebruch Henry O | EVP, Chief Strategy Officer | 41,623 | May 20, 2022 | 0 |
| Liddy Edward M | Director | – | Apr 4, 2022 | 0 |
| Schumacher Laura J | Vice Chairman | 248,002 | Mar 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2022 (view filing) | Mar 24 | 1 day | Stewart Jeffrey RyanEVP, Chief Commercial Officer | SSaleCommon Stock, $0.01 par value | −27.7K | $159.20 | −$4.41M | −31.2%60.9K after | |
| Mar 11, 2022 (view filing) | Mar 9 | 2 days | Durkin Brian LVP, Controller | SSaleCommon Stock, $0.01 par value | −18.6K | $150.01 | −$2.79M | −49.4%19.1K after | 2 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Gosebruch Henry OEVP, Chief Strategy Officer | SSaleCommon Stock, $0.01 par value | −15.0K | $148.26 | −$2.22M | −26.5%41.6K after | 3 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Sorg Elaine K.SVP, US Commercial Operations | SSaleCommon Stock, $0.01 par value | −6.48K | $148.28 | −$961.5K | −26.6%17.9K after | 3 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Richmond Timothy J.EVP, Chief HR Officer | SSaleCommon Stock, $0.01 par value | −26.4K | $148.26 | −$3.92M | −65.6%13.8K after | 3 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Stewart Jeffrey RyanEVP, Chief Commercial Officer | SSaleCommon Stock, $0.01 par value | −21.5K | $148.25 | −$3.19M | −26.1%60.9K after | 3 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Michael Robert A.Vice Chairman | SSaleCommon Stock, $0.01 par value | −43.1K | $148.25 | −$6.39M | −53.2%37.9K after | 3 lots |
| Feb 8, 2022 (view filing) | Feb 7 | 1 day | Strom Carrie CSVP & Pres Global Allerg Aesth | SSaleCommon Stock, $0.01 par value | −2.40K | $141.17 | −$338.2K | −5.3%42.5K after | |
| Dec 21, 2021 (view filing) | Dec 20 | 1 day | Durkin Brian LVP, Controller | SSaleCommon Stock, $0.01 par value | −11.8K | $128.51 | −$1.52M | −41.7%16.5K after | |
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Schumacher Laura JVice Chairman | SSaleCommon Stock, $0.01 par value | −181.7K | $130.24 | −$23.7M | −46.0%213.0K after | 2 lots |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Stewart Jeffrey RyanEVP, Chief Commercial Officer | SSaleCommon Stock, $0.01 par value | −2.15K | $128.00 | −$275.5K | −4.4%47.1K after | |
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Sorg Elaine K.SVP, US Commercial Operations | SSaleCommon Stock, $0.01 par value | −6.46K | $125.85 | −$812.7K | −100.0%0 after | 2 lots |
| Dec 10, 2021 (view filing) | Dec 9 | 1 day | Gonzalez Richard AChairman of the Board and CEO | SSaleCommon Stock, $0.01 par value | −174.1K | $123.23 | −$21.5M | −31.6%376.6K after | 2 lots |
| Dec 8, 2021 (view filing) | Dec 6 | 2 days | Richmond Timothy J.EVP, Chief HR Officer | SSaleCommon Stock, $0.01 par value | −50.4K | $120.00 | −$6.04M | −100.0%0 after | |
| Nov 4, 2021 (view filing) | Nov 2-3 | 2 days | Austin Roxanne SDirector | SSaleCommon Stock, $0.01 par value | −71.8K | $116.61 | −$8.38M | −59.3%49.3K after | 4 lots |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Strom Carrie CSVP & Pres Global Allerg Aesth | SSaleCommon Stock, $0.01 par value | −5.06K | $120.00 | −$606.8K | −9.0%51.0K after | |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Sorg Elaine K.SVP, US Commercial Operations | SSaleCommon Stock, $0.01 par value | −13.1K | $120.00 | −$1.57M | −53.0%11.6K after | 2 lots |